Metal–polyphenol network-based multifunctional materials for tumor therapy: Intrinsic properties, advances, and applications

Metal–polyphenol networks (MPNs), a novel class of nano-biomaterials, have recently emerged as promising candidates for tumor diagnosis and therapy due to their unique chemical tunability, excellent biocompatibility, and synergistic multifunctionality. Notably, MPNs can be synthesized via one-step or multi-step approaches, allowing precise control over their morphology, size, and drug-loading capacity. The versatility of MPNs is further demonstrated by their ability to integrate multiple therapeutic modalities, including chemotherapy, photothermal therapy, photodynamic therapy, and chemical dynamic therapy. Furthermore, through surface modification with targeted molecules, MPNs enable tumor-specific targeting while facilitating real-time therapeutic monitoring via multimodal imaging. Additionally, MPNs exhibit excellent biocompatibility and superior biodegradability, making them highly suitable for biomedical applications. This review systematically explores MPN synthesis strategies and physicochemical properties. It then comprehensively analyzes MPN-based biomaterials and their tumor therapeutic mechanisms. Furthermore, we evaluate the challenges in MPN clinical translation and propose future perspectives for precise tumor treatment using MPN-based platforms. Ultimately, this review highlights the transformative potential of MPNs in advancing tumor theranostics and lays the foundation for their future clinical applications. This paper provides a systematic review of MPNs, aims to offer new insights for designing next-generation MPN-based nanoplatforms with optimized tumor targeting and enhanced therapeutic efficacy.

Authors

Institutions

Publication Details

Journal
Acta Pharmaceutica Sinica B
Published
2025-12-02
DOI
https://doi.org/10.1016/j.apsb.2025.11.038
Primary Topic
Nanoplatforms for cancer theranostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Metal–polyphenol network-based multifunctional materials for tumor therapy: Intrinsic properties, advances, and applications

Phuong‐Thao Tran, Xinya Liu, Ling‐Wen Ding, Fen‐Er Chen et al.
Acta Pharmaceutica Sinica B
Nanoplatforms for cancer theranostics
article

Metal–polyphenol network-based multifunctional materials for tumor therapy: Intrinsic properties, advances, and applications

Phuong‐Thao Tran, Xinya Liu, Ling‐Wen Ding, Fen‐Er Chen, Junkai Cheng, Jiaqi Xian, Shuai Wang, Li Liu, Qin Wang, Qian Xu, Jian Gu, Yiman Wang
article en

Abstract

Metal–polyphenol networks (MPNs), a novel class of nano-biomaterials, have recently emerged as promising candidates for tumor diagnosis and therapy due to their unique chemical tunability, excellent biocompatibility, and synergistic multifunctionality. Notably, MPNs can be synthesized via one-step or multi-step approaches, allowing precise control over their morphology, size, and drug-loading capacity. The versatility of MPNs is further demonstrated by their ability to integrate multiple therapeutic modalities, including chemotherapy, photothermal therapy, photodynamic therapy, and chemical dynamic therapy. Furthermore, through surface modification with targeted molecules, MPNs enable tumor-specific targeting while facilitating real-time therapeutic monitoring via multimodal imaging. Additionally, MPNs exhibit excellent biocompatibility and superior biodegradability, making them highly suitable for biomedical applications. This review systematically explores MPN synthesis strategies and physicochemical properties. It then comprehensively analyzes MPN-based biomaterials and their tumor therapeutic mechanisms. Furthermore, we evaluate the challenges in MPN clinical translation and propose future perspectives for precise tumor treatment using MPN-based platforms. Ultimately, this review highlights the transformative potential of MPNs in advancing tumor theranostics and lays the foundation for their future clinical applications. This paper provides a systematic review of MPNs, aims to offer new insights for designing next-generation MPN-based nanoplatforms with optimized tumor targeting and enhanced therapeutic efficacy.

Acta Pharmaceutica Sinica BVol. 16(3)
National University of Singapore (SG), Peking University (CN), Fudan University (CN), Hanoi University of Pharmacy (VN), Southwest Minzu University (CN)
Openalex Percentile: Top 63%
Nanoplatforms for cancer theranostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.